Open Access
Thorac Cardiovasc Surg 2017; 65(S 02): S111-S142
DOI: 10.1055/s-0037-1598978
DGPK Oral Presentations
Sunday, February 12, 2017
DGPK: Basic Science and Clinical Studies
Georg Thieme Verlag KG Stuttgart · New York

Upregulation of Inflammatory Pathways in Mice with Hypertrophic Cardiomyopathy

Authors

  • S. Gornowitz

    1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
  • S. S. Raj

    1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
  • A. Petry

    1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
  • D. Kracun

    1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
  • Z. Zhang

    1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
  • A. Goerlach

    1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
  • P. Ewert

    1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
  • J. Schmitt

    2   Institute for Pharmacology and Clinical Pharmacology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
  • C.M. Wolf

    1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
02. Februar 2017 (online)

 

    Objectives: To assess the role of hypoxia-induced transcription factor (HIFs) and reactive oxygen species (ROS) on disease progression in a hypertrophic cardiomyopathy mouse model.

    Methods: Mice carrying the human Arg719Trp mutation in the α-cardiac myosin heavy chain gene (αMHC719/+) were compared with wildtypes (WT). Myocardial wall thickness was measured on M-mode in vivo echocardiographic imaging. RNA and protein expression of the myocardial HIF1α as well as components of the nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase was assessed ex vivo by real-time polymerase chain reaction (RT-PCR) and by western blot, respectively. ROS production was measured by electron paramagnetic resonance.

    Results: αMHC719/+ mice developed hypertrophic cardiomyopathy. Myocardial HIF1α expression was increased on both the RNA as well as the protein level in αMHC719/+ as compared with WT mice. There was an upregulation of p22phox, an essential component of the NADPH-oxidase, on a protein but not on the RNA-level in αMHC719/+ as compared with WT mice (see [Table 1]). αMHC719/+ mice showed an increase in relative ROS- and superoxide-generation.

    Table 1

    Results

    WT (N = 3–5)

    αMHC719/+ (N = 3–5)

    p-value

    Abbreviations: HIF1α, hypoxia inducible factor 1α; LVWT, left ventricular wall thickness.

    Data expressed in mean ± standard deviation.

    LVWT (Echocardiography) (mm)

    0.73 ± 0.05

    1.13 ± 0.08

    <0.001

    Relative mRNA HIF1α (RT-PCR) (-fold)

    1

    2.6 ± 0.4

    <0.01

    Relative mRNA expression p22phox (RT-PCR) (-fold)

    1

    1.3 ± 0.7

    NS

    Relative protein expression HIF1α (Western blot) (-fold)

    1

    3.2 ± 0.4

    <0.05

    Relative protein expression p22phox (Western blot)(-fold)

    1

    5.4 ± 0.3

    <0.05

    Conclusion: Activation of HIFs and increased ROS production suggest the influence of inflammatory pathways on pathogenesis in a murine HCM mouse model. These results might offer new treatment targets in HCM.


    Die Autoren geben an, dass kein Interessenkonflikt besteht.